1. Home
  2. CENT vs HRMY Comparison

CENT vs HRMY Comparison

Compare CENT & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Central Garden & Pet Company

CENT

Central Garden & Pet Company

HOLD

Current Price

$33.03

Market Cap

2.1B

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$35.95

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CENT
HRMY
Founded
1955
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.2B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CENT
HRMY
Price
$33.03
$35.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
8
Target Price
$50.00
$49.75
AVG Volume (30 Days)
66.8K
638.0K
Earning Date
02-04-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
57.41
50.44
EPS
2.55
3.17
Revenue
$3,129,064,000.00
$825,944,000.00
Revenue This Year
$2.17
$23.29
Revenue Next Year
$2.13
$15.98
P/E Ratio
$12.98
$11.38
Revenue Growth
N/A
21.13
52 Week Low
$28.77
$25.52
52 Week High
$41.25
$40.93

Technical Indicators

Market Signals
Indicator
CENT
HRMY
Relative Strength Index (RSI) 56.11 42.50
Support Level $31.41 $34.68
Resistance Level $32.57 $39.40
Average True Range (ATR) 0.60 1.25
MACD 0.05 -0.35
Stochastic Oscillator 84.85 27.97

Price Performance

Historical Comparison
CENT
HRMY

About CENT Central Garden & Pet Company

Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: